Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H32O2 |
Molecular Weight | 256.4241 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCC(O)=O
InChI
InChIKey=IPCSVZSSVZVIGE-UHFFFAOYSA-N
InChI=1S/C16H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h2-15H2,1H3,(H,17,18)
Molecular Formula | C16H32O2 |
Molecular Weight | 256.4241 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/26393565Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/12496284 | https://www.ncbi.nlm.nih.gov/pubmed/14717706 | https://www.ncbi.nlm.nih.gov/pubmed/18511927 | https://www.ncbi.nlm.nih.gov/pubmed/23406428
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26393565
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/12496284 | https://www.ncbi.nlm.nih.gov/pubmed/14717706 | https://www.ncbi.nlm.nih.gov/pubmed/18511927 | https://www.ncbi.nlm.nih.gov/pubmed/23406428
Palmitic acid is a saturated fatty acid, the principal constituent of refined palm oil, present in the diet and synthesized endogenously. Palmitic acid is able to activate the orphan G protein-coupled receptor GPR40. Palmitic acid was also a weak ligand of peroxisome proliferator-activated receptor gamma. Palmitic acid is a ligand of lipid chaperones - the fatty acid-binding proteins (FABPs). Dietary palm oil and palmitic acid may play a role in the development of obesity, type 2 diabetes mellitus, cardiovascular diseases and cancer.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL4422 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12496284 |
5.3 null [pEC50] | ||
Target ID: CHEMBL235 Sources: https://www.ncbi.nlm.nih.gov/pubmed/14717706 |
156.0 µM [Kd] | ||
Target ID: CHEMBL3344 |
|||
Target ID: CHEMBL2083 |
|||
Target ID: CHEMBL3674 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | SURFAXIN Approved UseSURFAXIN is indicated for the prevention of respiratory distress syndrome
(RDS) in premature infants at high risk for RDS. Launch Date2012 |
PubMed
Title | Date | PubMed |
---|---|---|
Fatty acid binding proteins from different tissues show distinct patterns of fatty acid interactions. | 2000 Jun 20 |
|
Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-induced insulin secretion? | 2001 Apr |
|
Lysosomal-type PLA2 and turnover of alveolar DPPC. | 2001 Apr |
|
Pulmonary surfactant protein SP-B is significantly more immunoreactive in anionic than in zwitterionic bilayers. | 2001 Apr 13 |
|
Structural characterization of lipopeptide agonists for the bradykinin B2 receptor. | 2001 Apr 15 |
|
Tolerance induction by acylated peptides: suppression of EAE in the mouse with palmitoylated PLP peptides. | 2001 Apr 2 |
|
Induction of apoptosis through B-cell receptor cross-linking occurs via de novo generated C16-ceramide and involves mitochondria. | 2001 Apr 27 |
|
Participation of carnitine palmitoyltransferase in the synthesis of dipalmitoylphosphatidylcholine in rat alveolar type II cells. | 2001 Feb |
|
Fatty acid-induced apoptosis in neonatal cardiomyocytes: redox signaling. | 2001 Feb |
|
Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids. | 2001 Feb |
|
Breed effects on growth performance, carcass characteristics, fatty acid composition, and palatability attributes in finishing steers. | 2001 Feb |
|
Effect of lipopolysaccharide and cytokines on oxidative metabolism in neonatal rat hepatocytes. | 2001 Feb |
|
5-Hydroxytryptamine 4(a) receptor expressed in Sf9 cells is palmitoylated in an agonist-dependent manner. | 2001 Feb 1 |
|
Unsaturated fatty acids down-regulate srebp isoforms 1a and 1c by two mechanisms in HEK-293 cells. | 2001 Feb 9 |
|
The composition of saturated fatty acids in plasma phospholipids changes in a way to counteract changes in the mean melting point during pregnancy. | 2001 Jan |
|
Effect of long-chain fatty acids in the culture medium on fatty acid composition of WEHI-3 and J774A.1 cells. | 2001 Jan |
|
Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. | 2001 Jan |
|
Chronic effects of different fatty acids and leptin in INS-1 cells. | 2001 Jan |
|
Characterization of a novel triphosphonooctaosylceramide from the eggs of the sea hare, Aplysia kurodai. | 2001 Jan |
|
Relationship between the concentrations of plasma phospholipid stearic acid and plasma lipoprotein lipids in healthy men. | 2001 Jan |
|
Characterization of a new member of the fatty acid-binding protein family that binds all-trans-retinol. | 2001 Jan 12 |
|
Rhamnolipid production by Pseudomonas aeruginosa under denitrification: effects of limiting nutrients and carbon substrates. | 2001 Jan 5 |
|
Acylation of lysine 983 is sufficient for toxin activity of Bordetella pertussis adenylate cyclase. Substitutions of alanine 140 modulate acylation site selectivity of the toxin acyltransferase CyaC. | 2001 Jan 5 |
|
Systemic and regional free fatty acid metabolism in type 2 diabetes. | 2001 Jun |
|
Gbeta gamma isoforms selectively rescue plasma membrane localization and palmitoylation of mutant Galphas and Galphaq. | 2001 Jun 29 |
|
Anaerobic biodegradation of alkanes by enriched consortia under four different reducing conditions. | 2001 Mar |
|
Optimization of methods and treatment conditions for studying effects of fatty acids on cell growth. | 2001 Mar |
|
Effects of diets enriched in n-6 or n-3 fatty acids on cholesterol metabolism in older rats chronically fed a cholesterol-enriched diet. | 2001 Mar |
|
Gas chromatographic analysis of total fatty acids in cider. | 2001 Mar |
|
Modelling of hexadecane degradation in continuous-flow cultures. | 2001 Mar |
|
Atomic resolution structure analysis of beta' polymorph crystal of a triacylglycerol: 1,2-dipalmitoyl-3-myristoyl-sn-glycerol. | 2001 Mar |
|
Role of fatty acids in the recovery of cardiac function during resuscitation from hemorrhagic shock. | 2001 Mar |
|
Free fatty acids, but not ketone bodies, protect diabetic rat hearts during low-flow ischemia. | 2001 Mar |
|
Increased uncoupling proteins and decreased efficiency in palmitate-perfused hyperthyroid rat heart. | 2001 Mar |
|
Flux-balance analysis of mitochondrial energy metabolism: consequences of systemic stoichiometric constraints. | 2001 Mar |
|
Effect of nicotinic acid administration on hepatic very low density lipoprotein-triglyceride production. | 2001 Mar |
|
Glucose metabolism in perfused mouse hearts overexpressing human GLUT-4 glucose transporter. | 2001 Mar |
|
Expression of rat liver long-chain acyl-CoA synthetase and characterization of its role in the metabolism of R-ibuprofen and other fatty acid-like xenobiotics. | 2001 Mar 15 |
|
Regulation of G proteins by covalent modification. | 2001 Mar 26 |
|
[Branched alkanes and other apolar compounds produced by the cyanobacterium Microcoleus vaginatus from the Negev desert]. | 2001 Mar-Apr |
|
Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability. | 2001 May |
|
Identification and quantitation of unique fatty acid oxidation products in human atherosclerotic plaque using high-performance liquid chromatography. | 2001 May 15 |
|
Palmitate-induced apoptosis can occur through a ceramide-independent pathway. | 2001 May 4 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18710535
The conditioned media from palmitic acid (0.2 mM) treated rat cortical astroglia, but not the cerebellar astroglia, significantly elevated levels of phosphorylated tau and BACE1 in cortical neurons as compared to controls
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:01:00 GMT 2023
by
admin
on
Fri Dec 15 15:01:00 GMT 2023
|
Record UNII |
2V16EO95H1
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
47641-6
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
NCI_THESAURUS |
C68421
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
LOINC |
55873-4
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
LOINC |
2719-3
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/04/217
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
LOINC |
74625-5
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
DSLD |
1603 (Number of products:186)
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
LOINC |
75115-6
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
NCI_THESAURUS |
C68388
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
LOINC |
35161-9
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
JECFA EVALUATION |
PALMITIC ACID
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
CFR |
21 CFR 172.860
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
CFR |
21 CFR 357.210
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
LOINC |
74624-8
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5030
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
LL-31
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
15756
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
1492007
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
PALMITIC ACID
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
57-10-3
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
100000091751
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
m8367
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | Merck Index | ||
|
5001
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
CHEMBL82293
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
C61873
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
1091
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
1426390
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | RxNorm | ||
|
SUB14744MIG
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
985
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
2V16EO95H1
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
200-312-9
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
7896
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
2V16EO95H1
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
DB03796
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
DTXSID2021602
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
1370621
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
ALTERNATIVE | |||
|
D019308
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
USP
|
||
|
LIPID -> FATTY ACID |
Values are % of total.
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
USP
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
USP
|
||
|
LIPID -> FATTY ACID |
Value is fatty acid composition (%) for international corn oil w/std. deviation of 1.4%
LR Strecker, et al; Proc World Conf Edible Fats & Oils Proc, Amer Oil Chem Soc, pp-309-323(1990)
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
LIPID -> FATTY ACID |
Value is % of total fatty acids.
Maiti, S, et al; Handbook of Annual Oilseed Crops, OIBH, New Delhi, India(1988), pp.1987-90
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
LIPID -> FATTY ACID |
Values given are in undefined precent.
Average is typical for U.S. Sunflower oil.
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Compound measured as 23.50% of the composition of the steam distillate of Elymus repens rhizome as per R Boesel in Planta Medica iss:4 pg:399-400, 1989.
|
||
|
SALT/SOLVATE -> PARENT | |||
|
LIPID -> FATTY ACID |
G Jurriens and ACJ Kroesen, J Am Oil Chem Soc, 42(9)(1965)(average value).
Range values as of FAO/WHO Codex Alimentarius Committee on commercial fats and oils.(unspecified percent)
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
LIPID -> FATTY ACID |
Value is fatty acid composition (%) for US corn oil w/std. deviation of 0.55%
LR Strecker, et al; Proc World Conf Edible Fats & Oils Proc, Amer Oil Chem Soc, pp-309-323(1990)
|
||
|
LIPID -> FATTY ACID |
Values are % of weight of fatty acid composition.
O?Connor, RT, Herb, SF; J Am Oil Chem Soc 47, 186A, 195A, 197A(1970)(range)
Brignoli, CA et al: J Am Diet Assoc 68, 224(1976)(average)
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
USP
|
||
|
SALT/SOLVATE -> PARENT | |||
|
LIPID -> FATTY ACID |
U.S produced rice oil. Values are % of composition.
|
||
|
LIPID -> FATTY ACID |
TURKISH SOURCE
|
||
|
LIPID -> FATTY ACID |
VARIES ACCORDING TO METHOD OF EXTRACTION.
|
||
|
SALT/SOLVATE -> PARENT | |||
|
LIPID -> FATTY ACID |
Value is % of composition.
Oleic safflower variety UC-1 cited by Knowles, P, Calif. Agr. 19(12), 15(1965), produced 4.5% by composition.
|
||
|
LIPID -> FATTY ACID |
MAY BE PRESENT
USP
|
||
|
LIPID -> FATTY ACID |
Values are % of total.
|
||
|
LIPID -> FATTY ACID |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
LIPID -> FATTY ACID |
JB Rossell and co-workers; JAOCS62(2), 221-230(1985).
Range weight is a mean.
|
||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|